Insiders · Profile

Ordentlich Peter

Chief Scientific Officer at Syndax Pharmaceuticals. Filing since 17 May 2017. CIK 0001594274

Company

Date

Role

Action

Shares

Amount

Of holding

SNDX Syndax Pharmaceuticals Inc

15 Feb 2023

Chief Scientific Officer

Sold, plan not stated

25,000

$646.09K

100%

SNDX Syndax Pharmaceuticals Inc

1 Feb 2023

Chief Scientific Officer

Sold, plan not stated

69

$1.96K

100%

SNDX Syndax Pharmaceuticals Inc

2 Dec 2022

Chief Scientific Officer

Sold, plan not stated

17,200

$430.94K

98.5%

SNDX Syndax Pharmaceuticals Inc

1 Dec 2022

Chief Scientific Officer

Sold, plan not stated

7,800

$195.09K

96.7%

SNDX Syndax Pharmaceuticals Inc

24 Aug 2022

Chief Scientific Officer

Sold, plan not stated

25,000

$625.89K

99.0%

SNDX Syndax Pharmaceuticals Inc

1 Feb 2022

Chief Scientific Officer

Sold, plan not stated

1,412

$23.51K

100%

SNDX Syndax Pharmaceuticals Inc

23 Nov 2020

Chief Scientific Officer

Sold, plan not stated

29,972

$694.12K

100%

SNDX Syndax Pharmaceuticals Inc

3 Apr 2018

Chief Scientific Officer

Sold, plan not stated

7,500

$112.50K

100%

SNDX Syndax Pharmaceuticals Inc

17 May 2017

Chief Scientific Officer

Sold, plan not stated

5,000

$75.00K

100%

9 decisions on file.